MedTrace Logo

The Study to Assess AMI Treated With Balloon Angioplasty.

NCT00232830 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 715

Last updated 2009-09-16

No results posted yet for this study

Summary

The main objective of this study is to assess the effectiveness and safety of the CYPHER™ (CYPHER SELECT™) (Sirolimus-eluting) stent in reducing the occurrence of a composite endpoint of target vessel failure (TVF) in subjects treated for acute myocardial infarction as compared to a bare metal stent.

Conditions

Interventions

DEVICE

drug-eluting stent

Cypher Sirolimus-eluting Coronary Stent

DEVICE

bare-metal stent

any bare-metal stent brand

Sponsors & Collaborators

  • Cordis Corporation

    lead INDUSTRY

Principal Investigators

  • Christian Spaulding, MD · HOPITAL COCHIN, René Descartes University

  • Christoph Bode, MD · University of Freiburg, Albert-Ludwigs-Universitätskliniken

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Primary Completion
2009-02-28
Completion
2009-04-30

Countries

  • France
  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00232830 on ClinicalTrials.gov